I thought I was too old to start in my 70s, but I told myself, Its not too late, and Im so happy I did
GLP-1 medications are recommended in the ADA Standards of Care for those with cardiovascular disease, heart failure, and/or kidney disease to reduce the risk of adverse events due to these conditions
GLP-1 microdosing may appeal to people who are interested in metabolic support but are cautious about traditional higher-dose protocols
Oh YS, Jun HS (2017) Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
That can make microdosing attractive for people who are nervous about side effects, sensitive to medications, or interested in a slower and more conservative approach
The honest answer may be that you need pharmaceutical intervention, and there is nothing wrong with that decision